Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02883556 |
|---|---|
| Brief Title: | Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin (CARSKIN) |
| First Submitted : | August 25, 2016 |
| First Submitted that Met QC Criteria : | August 29, 2016 |
| First Posted : | August 30, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 12, 2021 |
| Last Update Posted : | January 13, 2021 |